Etomidate and alfentanil infusion for major surgery

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Intravenous anesthesia offers advantages in controlling drug delivery during surgery.
• Etomidate and alfentanil are potent anesthetic agents with distinct pharmacokinetic profiles.

Purpose of the Study:

• To evaluate the efficacy and safety of a combined intravenous infusion of etomidate and alfentanil for inducing and maintaining anesthesia in patients undergoing major surgery.
• To assess the recovery profile associated with this anesthetic technique.

Main Methods:

• Twenty patients undergoing major surgery received an intravenous infusion of etomidate (0.2 mg/kg) and alfentanil (8 micrograms/kg) for anesthesia induction.
• Anesthesia maintenance was achieved via continuous infusion, adjusted based on cardiovascular, EEG, and EMG monitoring.
• Muscle relaxation was facilitated by alcuronium, and the infusion was discontinued a mean of 7.3 minutes before surgical completion.

Main Results:

• The combined etomidate and alfentanil infusion technique proved clinically successful in inducing and maintaining anesthesia.
• Patients experienced effective anesthesia with a rapid recovery period.
• The Datex ABM monitoring system was utilized for optimal control of the intravenous anesthesia.

Conclusions:

• Intravenous infusion of etomidate and alfentanil is a viable and effective method for anesthesia during major surgery.
• The technique facilitates rapid recovery, highlighting its clinical utility.
• Close patient monitoring is crucial for optimizing the control and safety of intravenous anesthetic techniques.